D Courtney1, F McDermott, A Heeney, D C Winter. 1. Department of Surgery, St Vincent's University Hospital, Elm Park, Dublin 4, Republic of Ireland, nichurnd@tcd.ie.
Abstract
AIM: Recurrent and locally advanced colorectal cancers frequently require en bloc resection of involved organs to achieve negative margins. The aim of this review is to evaluate the most current literature related to the surgical management of locally advanced and recurrent colorectal cancer. METHODS: A literature review was performed on the electronic databases MEDLINE from PubMed, EMBASE and the Cochrane library for publications in the English language from January 1993 to July 2013. The MeSH search terms 'locally advanced colorectal cancer', 'recurrent colorectal cancer' and 'surgical management' were used. RESULTS: A total of 1,470 patients with recurrent or locally advanced primary colorectal cancer were included in 22 studies. Surgical removal of the tumour with negative margins (R0) offers the best prognosis in term of survival with a 5-year survival of up to 70 %. MVR is needed in approximately 10 % with the most commonly involved organ being the bladder. The mean post-operative morbidity is 40 %, mainly relating to superficial surgical site infection, pelvic collections and delayed wound healing. Most patients will undergo radiotherapy and/or chemotherapy pre- or post-operatively. The mean 5-year overall survival for R0 resection is 50 % for recurrent and locally advanced primary tumours while survival following R1 or R2 is 12 and <5 %, respectively. CONCLUSION: Multimodal therapy and extended surgery to achieve clear margins offers good prognosis to patients with recurrent and locally advanced colorectal cancers.
AIM: Recurrent and locally advanced colorectal cancers frequently require en bloc resection of involved organs to achieve negative margins. The aim of this review is to evaluate the most current literature related to the surgical management of locally advanced and recurrent colorectal cancer. METHODS: A literature review was performed on the electronic databases MEDLINE from PubMed, EMBASE and the Cochrane library for publications in the English language from January 1993 to July 2013. The MeSH search terms 'locally advanced colorectal cancer', 'recurrent colorectal cancer' and 'surgical management' were used. RESULTS: A total of 1,470 patients with recurrent or locally advanced primary colorectal cancer were included in 22 studies. Surgical removal of the tumour with negative margins (R0) offers the best prognosis in term of survival with a 5-year survival of up to 70 %. MVR is needed in approximately 10 % with the most commonly involved organ being the bladder. The mean post-operative morbidity is 40 %, mainly relating to superficial surgical site infection, pelvic collections and delayed wound healing. Most patients will undergo radiotherapy and/or chemotherapy pre- or post-operatively. The mean 5-year overall survival for R0 resection is 50 % for recurrent and locally advanced primary tumours while survival following R1 or R2 is 12 and <5 %, respectively. CONCLUSION: Multimodal therapy and extended surgery to achieve clear margins offers good prognosis to patients with recurrent and locally advanced colorectal cancers.
Authors: J Hida; M Yasutomi; T Maruyama; A Nakajima; T Uchida; T Wakano; T Tokoro; K Fujimoto Journal: Dis Colon Rectum Date: 1998-02 Impact factor: 4.585
Authors: Leonard L Gunderson; Jonathan B Ashman; Michael G Haddock; Ivy A Petersen; Adyr Moss; Jacques Heppell; Richard J Gray; Barbara A Pockaj; Heidi Nelson; Christopher Beauchamp Journal: Surg Oncol Clin N Am Date: 2013-03-13 Impact factor: 3.495
Authors: Lieve G J Leijssen; Anne M Dinaux; R Amri; Hiroko Kunitake; Liliana G Bordeianou; David L Berger Journal: J Gastrointest Surg Date: 2018-10-03 Impact factor: 3.452
Authors: Fortuné M K Elekonawo; Susanne Lütje; Gerben M Franssen; Desirée L Bos; David M Goldenberg; Otto C Boerman; Mark Rijpkema Journal: EJNMMI Res Date: 2019-09-04 Impact factor: 3.138